← Open Payments lookup

KATHARINE INGRAM: Open Payments

NPI 1871208462 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$651 in 31 payments from 17 companies in 2025. Trend: 2023 $306 · 2024 $592 · 2025 $651

Food & beverage: $651
CompanyPaymentsAmount
PFIZER INC.7$151
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$95
Otsuka America Pharmaceutical, Inc.3$64
Lundbeck LLC2$47
ABBVIE INC.2$40
Lilly USA, LLC2$35
Bayer Healthcare Pharmaceuticals Inc.1$29
GlaxoSmithKline, LLC.1$29
Takeda Pharmaceuticals U.S.A., Inc.1$26
Phathom Pharmaceuticals, Inc.1$20

Products named: NURTEC ODT, REXULTI, CAPLYTA, JARDIANCE, Kerendia, TRELEGY ELLIPTA, TRINTELLIX, QULIPTA.

Industry payments across MD — which companies pay providers there.